Open AccessAn Overview on the Ongoing Clinical Trials of COVID-19 Vaccines
Author(s) -
Syeda Komal Fatima,
Ameena Tur Rasool,
Ayesha Sabir,
Gul Shahnaz
Publication year - 2020
Language(s) - English
DOI - 10.31703/giidr.2020(v-i).05
Subject(s) - clinical trial , pandemic , covid-19 , medicine , intensive care medicine , clinical endpoint , vaccine trial , virology , infectious disease (medical specialty) , disease , pathology , outbreak
COVID-19 has posed a great threat to mankind, there is a dire need to introduce a vaccine to combat this global pandemic. Several vaccines are underway to complete their phase 3 clinical trials. This article highlights events surrounding the ongoing clinical trials of vaccines effective against COVID-19, and different procedures and formalities the vaccine will have to endure to get EUA. Clinical trials are discussed stepwise along with the clinical endpoint desired at the end of these trials. In line with antimicrobial resistance, vaccine resistance has also emerged in this era and needs focused consideration, and the probability of development of resistance in these vaccines is discussed. This article specifically covers the latest research reporting clinical efficacy, safety profile, and adverse events following the administration of doses to patients and concerns regarding the rushed approval of vaccines. Four vaccines have been discussed in detail; BNT162b2, mRNA-1273, Sputnik V, ChAdOx1.